Discontinuation report BLEPHAMIDE

Last updated on 2021-12-02 History
Report ID 150359
Drug Identification Number 00807788
Brand name BLEPHAMIDE
Common or Proper name Sulfacetamide/Prednisolone suspension
Company Name ALLERGAN INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) PREDNISOLONE ACETATE SULFACETAMIDE SODIUM
Strength(s) 0.2% 10%
Dosage form(s) DROPS
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5mL and 10mL
ATC code S01CA
ATC description ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB
Reason for discontinuation Business reasons
Anticipated discontinuation date 2022-01-31
Actual discontinuation date
Remaining supply date 2022-01-31
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-12-02 English Compare
v2 2021-12-02 French Compare

Showing 1 to 2 of 2